These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31256114)

  • 21. Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC.
    Biswas T; Efird JT; Prasad S; James SE; Walker PR; Zagar TM
    Clin Breast Cancer; 2016 Jun; 16(3):212-6. PubMed ID: 26988771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
    Li BD; Sicard MA; Ampil F; Abreo F; Lilien D; Chu QD; Burton GV
    Oncology; 2010; 79(1-2):3-12. PubMed ID: 21051912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
    Rosso KJ; Tadros AB; Weiss A; Warneke CL; DeSnyder S; Kuerer H; Ueno NT; Stecklein SR; Woodward WA; Lucci A
    Ann Surg Oncol; 2017 Oct; 24(10):2981-2988. PubMed ID: 28766220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial response to chemotherapy, not delay in diagnosis, predicts overall survival in inflammatory breast cancer cases.
    Hoffman HJ; Khan A; Ajmera KM; Zolfaghari L; Schenfeld JR; Levine PH
    Am J Clin Oncol; 2014 Aug; 37(4):315-21. PubMed ID: 23241503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modern outcomes of inflammatory breast cancer.
    Rehman S; Reddy CA; Tendulkar RD
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):619-24. PubMed ID: 22445003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily radiation therapy for inflammatory breast cancer.
    Brown L; Harmsen W; Blanchard M; Goetz M; Jakub J; Mutter R; Petersen I; Rooney J; Stauder M; Yan E; Laack N
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):997-1003. PubMed ID: 24721591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.
    Gong Y; Huo L; Liu P; Sneige N; Sun X; Ueno NT; Lucci A; Buchholz TA; Valero V; Cristofanilli M
    Cancer; 2011 Dec; 117(24):5476-84. PubMed ID: 21713757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory breast cancer: the disease, the biology, the treatment.
    Robertson FM; Bondy M; Yang W; Yamauchi H; Wiggins S; Kamrudin S; Krishnamurthy S; Le-Petross H; Bidaut L; Player AN; Barsky SH; Woodward WA; Buchholz T; Lucci A; Ueno NT; Cristofanilli M
    CA Cancer J Clin; 2010; 60(6):351-75. PubMed ID: 20959401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI features of inflammatory breast cancer.
    Le-Petross HT; Cristofanilli M; Carkaci S; Krishnamurthy S; Jackson EF; Harrell RK; Reed BJ; Yang WT
    AJR Am J Roentgenol; 2011 Oct; 197(4):W769-76. PubMed ID: 21940550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy.
    Harada TL; Uematsu T; Nakashima K; Kawabata T; Nishimura S; Takahashi K; Tadokoro Y; Hayashi T; Tsuchiya K; Watanabe J; Sugino T
    Radiology; 2021 Apr; 299(1):53-62. PubMed ID: 33560188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
    El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
    Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
    Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
    Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer.
    Loi M; Dunant A; Ghith S; Cascales-Garcia AM; Mazouni C; Pistilli B; Mathieu MC; Deutsch E; Arriagada R; Rivera S
    Cancer Invest; 2019; 37(1):29-38. PubMed ID: 30656969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).
    Slaoui M; Zoure AA; Mouh FZ; Bensouda Y; El Mzibri M; Bakri Y; Amrani M
    BMC Cancer; 2018 Jul; 18(1):713. PubMed ID: 29976157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction.
    Raghav K; French JT; Ueno NT; Lei X; Krishnamurthy S; Reuben JM; Valero V; Ibrahim NK
    PLoS One; 2016; 11(1):e0145534. PubMed ID: 26752563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery.
    Brzezinska M; Williams LJ; Thomas J; Michael Dixon J
    Breast Cancer Res Treat; 2016 Dec; 160(3):387-391. PubMed ID: 27757718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
    Charafe-Jauffret E; Tarpin C; Bardou VJ; Bertucci F; Ginestier C; Braud AC; Puig B; Geneix J; Hassoun J; Birnbaum D; Jacquemier J; Viens P
    J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
    Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
    Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory breast carcinoma: a community hospital experience.
    Brooks HL; Mandava N; Pizzi WF; Shah S
    J Am Coll Surg; 1998 Jun; 186(6):622-9. PubMed ID: 9632147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the incidence of inflammatory breast cancer using population- and hospital-based cancer registries in Casablanca, Morocco.
    Gunden JR; Bendahhou K; Benider A; Ibrahim Khalil A; Khalis M; Wilson ML; Soliman AS
    Breast Dis; 2019; 38(2):39-45. PubMed ID: 31104003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.